DWTX
NASD Dogwood Therapeutics Inc$1.25 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.25, $0.04 below the day’s high of $1.29
- YTD change
- -69.95%
- vs 20-day SMA
- -13.76%
- vs 200-day SMA
- -41.05%
Price ranges
Price & Performance
-0.31 (-19.87%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 95.7% away from all-time highs of $29.28
- DWTX is down 70% since the beginning of the year
- DWTX is down 79% over the past 12 months
- DWTX is down 26% over the past 1 month
- 0% of all DWTX investors are betting against DWTX
DWTX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -79.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -12.59%
- vs 8-day SMA
- -10.87%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.